IL-28, IL-29 and their class II cytokine receptor IL-28R

Cytokines play a critical role in modulating the innate and adaptive immune systems. Here, we have identified from the human genomic sequence a family of three cytokines, designated interleukin 28A (IL-28A), IL-28B and IL-29, that are distantly related to type I interferons (IFNs) and the IL-10 family. We found that like type I IFNs, IL-28 and IL-29 were induced by viral infection and showed antiviral activity. However, IL-28 and IL-29 interacted with a heterodimeric class II cytokine receptor that consisted of IL-10 receptor β (IL-10Rβ) and an orphan class II receptor chain, designated IL-28Rα. This newly described cytokine family may serve as an alternative to type I IFNs in providing immunity to viral infection.

[1]  S. Karlin,et al.  Prediction of complete gene structures in human genomic DNA. , 1997, Journal of molecular biology.

[2]  G. Lutfalla,et al.  Genetic transfer of a functional human interferon α receptor into mouse cells: Cloning and expression of its c-DNA , 1990, Cell.

[3]  I. Salmon,et al.  Interleukin-3 and interferon beta cooperate to induce differentiation of monocytes into dendritic cells with potent helper T-cell stimulatory properties. , 2002, Blood.

[4]  S. Pestka,et al.  Identification of the Functional Interleukin-22 (IL-22) Receptor Complex , 2001, The Journal of Biological Chemistry.

[5]  C. Biron.  Role of early cytokines, including alpha and beta interferons (IFN-α\β), in innate and adaptive immune responses to viral infections☆ , 1998 .

[6]  Scott R. Presnell,et al.  A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. de Waal Malefyt,et al.  Expression cloning and characterization of a human IL-10 receptor. , 1994, Journal of immunology.

[8]  J. Darnell,et al.  Stat3 Recruitment by Two Distinct Ligand-induced, Tyrosine-phosphorylated Docking Sites in the Interleukin-10 Receptor Intracellular Domain* , 1996, The Journal of Biological Chemistry.

[9]  G von Heijne,et al.  Patterns of amino acids near signal-sequence cleavage sites. , 1983, European journal of biochemistry.

[10]  Philip Lijnzaad,et al.  The Ensembl genome database project , 2002, Nucleic Acids Res..

[11]  Zemin Zhang,et al.  Interleukin (IL)-22, a Novel Human Cytokine That Signals through the Interferon Receptor-related Proteins CRF2–4 and IL-22R* , 2000, The Journal of Biological Chemistry.

[12]  G. Stark,et al.  How cells respond to interferons. , 1998, Annual review of biochemistry.

[13]  B. Cohen,et al.  The human interferon α β receptor: Characterization and molecular cloning , 1994, Cell.

[14]  G. Dusheiko.  Side effects of α interferon in chronic hepatitis C , 1997, Hepatology.

[15]  Y. Matsuzawa,et al.  Limitin: An interferon-like cytokine that preferentially influences B-lymphocyte precursors , 2000, Nature Medicine.

[16]  M. Hansen,et al.  A new sensitive bioassay for precise quantification of interferon activity as measured via the mitochondrial dehydrogenase function in cells (MTT‐method) , 1990, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[17]  A. Hruza,et al.  Zinc mediated dimer of human interferon-alpha 2b revealed by X-ray crystallography. , 1996, Structure.

[18]  T. Mosmann,et al.  IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.

[19]  J. Tavernier,et al.  Down-modulation of Type 1 Interferon Responses by Receptor Cross-competition for a Shared Jak Kinase* , 2001, The Journal of Biological Chemistry.

[20]  J. Renauld,et al.  Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Bazan,et al.  Structural design and molecular evolution of a cytokine receptor superfamily. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[22]  P. Moore,et al.  Interferon-κ, a Novel Type I Interferon Expressed in Human Keratinocytes* , 2001, The Journal of Biological Chemistry.

[23]  G. Lutfalla,et al.  Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA. , 1990, Cell.

[24]  K C Zoon,et al.  Interferons and their actions. , 1987, Annual review of biochemistry.

[25]  S. Kotenko.  The family of IL-10-related cytokines and their receptors: related, but to what extent? , 2002, Cytokine & growth factor reviews.

[26]  M. Fellous,et al.  Interferon-dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[27]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[28]  Wei Wu,et al.  Identification and functional characterization of a second chain of the interleukin‐10 receptor complex , 1997, The EMBO journal.

[29]  N. Raj,et al.  Two levels of regulation of beta-interferon gene expression in human cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[30]  S. Pestka,et al.  A convenient and rapid cytopathic effect inhibition assay for interferon. , 1981, Methods in enzymology.

[31]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[32]  A Wlodawer,et al.  Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma. , 1995, Structure.

[33]  J U Gutterman,et al.  Cytokine therapeutics: lessons from interferon alpha. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[34]  C G Figdor,et al.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.

[35]  P. Marrack,et al.  Type I Interferons Keep Activated T Cells Alive , 1999, The Journal of experimental medicine.

[36]  D. Conklin,et al.  Interleukin 20 Discovery, Receptor Identification, and Role in Epidermal Function , 2001, Cell.